Roche Pharma (Switzerland) Ltd is Roche's Swiss national affiliate and its approximately 180 employees ensure that patients in Switzerland have access to Roche's innovative portfolio of medicines. Its therapeutic areas focus on oncology, rheumatology, pneumology, neurology and rare diseases. In 2020, around 177,000 patients in Switzerland were treated with a Roche medicine.

In order for a drug to be successfully delivered to patients, a large number of activities are required on the part of Roche Pharma Switzerland. These include support for clinical trials, filing for regulatory approval, scientific documentation, medical information, marketing, registration and quality assurance, pricing, and distribution including packaging and package inserts.

In order to exploit the possibilities of modern medicine for the benefit of all patients, Roche works closely with other healthcare players. Personalized healthcare will play a key role here in the future. As a leading pharmaceutical company in this field, we rely on our unique combination of diagnostics, medicines and data analysis and work closely with our colleagues at Roche Diagnostics.

For 125 years, we have been committed to improving people's lives. Our commitment goes far beyond developing innovative diagnostics and therapeutics. Our greatest contribution to patients and society is sustainable innovation, true to our motto "better outcomes for more patients faster".

Our management team


Thomas F. Schmidt 

General Manager Switzerland

Remo Christen Director Market Access & Health Care Affairs
Dr. med. Jean-Marc C. Häusler Country Medical Director
Dr. Sven Inäbnit Director Governmental Affairs, Quality & Compliance
Sandrine Vogt Director Finance and Business Partnering
Rebecca Herdtweck Director Human Resources
Marios Ntinis Director Business Unit Neuroscience, Autoimmune & Rare Diseases
Dr. Sigrid Welte Business Unit Haematology, Oncology, Personalised Healthcare

Our mission

The values of integrity, courage and passion inspire the whole company and are carried all around the world. In Switzerland, too, we are working with integrity, courage and passion to give patients a better quality of life through faster access to new medicines. Innovation through scientific excellence is our answer to medical needs. Our goal is to permanently conquer diseases – through our combined efforts and with open minds.

Purpose of the Roche Group


Cooperation with service providers
ROCHE General Terms & Conditions for Service Contracts (PDF)
ROCHE General Terms & Conditions for Contracts of Work and Services (PDF)